Chi-Kong Li
Overview
Explore the profile of Chi-Kong Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang W, Cai J, Wang X, Ma Y, Zhu X, Yu J, et al.
Blood
. 2025 Jan;
PMID: 39786460
We evaluated the prognostic and therapeutic significance of measurable residual disease (MRD) during remission induction in pediatric acute lymphoblastic leukemia (ALL) patients. In the CCCG-ALL-2015 protocol, 7640 patients were categorized...
2.
Luo X, Cheng C, Cheng C, Chan H, Leung K, Leung K, et al.
Blood Adv
. 2024 Dec;
9(6):1286-1292.
PMID: 39705539
No abstract available.
3.
Conter V, Valsecchi M, De Lorenzo P, Gandemer V, Heyman M, Saha V, et al.
Haematologica
. 2024 Jul;
109(11):3766-3770.
PMID: 39021218
No abstract available.
4.
Kimura S, Park C, Montefiori L, Iacobucci I, Polonen P, Gao Q, et al.
Cancer Discov
. 2024 Jun;
14(10):1838-1859.
PMID: 38916500
Acute lymphoblastic leukemia expressing the gamma delta T-cell receptor (γδ T-ALL) is a poorly understood disease. We studied 200 children with γδ T-ALL from 13 clinical study groups to understand...
5.
Lin S, Liao N, Li X, Yang L, He Y, Tang Y, et al.
Eur J Haematol
. 2024 Jun;
113(3):357-370.
PMID: 38847134
Background: IKZF1 deletion (IKZF1) is associated with poor prognosis in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). But the prognosis of IKZF1 combined with other prognostic stratification factors remains unclear. Whether...
6.
Leung A, Cai J, Wan Z, Qin J, Fang Y, Sun L, et al.
Haematologica
. 2024 Apr;
109(8):2726-2731.
PMID: 38634141
No abstract available.
7.
Kimura S, Polonen P, Montefiori L, Park C, Iacobucci I, Yeoh A, et al.
medRxiv
. 2023 Nov;
PMID: 37986997
Purpose: Gamma delta T-cell receptor-positive acute lymphoblastic leukemia (γδ T-ALL) is a high-risk but poorly characterized disease. Methods: We studied clinical features of 200 pediatric γδ T-ALL, and compared the...
8.
Cai J, Liu H, Chen Y, Yu J, Gao J, Jiang H, et al.
Lancet Reg Health West Pac
. 2023 Oct;
38:100818.
PMID: 37790080
Background: First-generation ABL-targeted tyrosine kinase inhibitor (TKI) imatinib is known to retard growth in children but it is not known if the second-generation ABL-targeted TKI dasatinib has the same effect....
9.
Li C, Kurkure P, Arora R, Chen B, Kirgizov K, Okamoto Y, et al.
JCO Glob Oncol
. 2023 Sep;
9:e2300153.
PMID: 37656946
In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups....
10.
Cheng C, Yung Y, Chan H, Leung K, Chan K, Leung A, et al.
Commun Biol
. 2023 Mar;
6(1):356.
PMID: 37002311
Pediatric acute myeloid leukemia (AML) is an uncommon but aggressive hematological malignancy. The poor outcome is attributed to inadequate prognostic classification and limited treatment options. A thorough understanding on the...